The Big Lp(a) Drug Failed: What First Responders Do Now

If you got your Lp(a) checked after reading our guide on the cholesterol numbers your department physical skips, you may have been waiting on the same thing cardiologists were: the first drug built to lower it. In early September, Novartis announced that pelacarsen — the most advanced Lp(a)-lowering drug in the world — failed its landmark outcomes trial. For the roughly one in five people walking around with elevated Lp(a), including a lot of cops and firefighters who found out through a $50 add-on lab, that news matters. Here’s what actually happened, and what it changes for you.

What Happened in Lp(a)HORIZON

Lp(a)HORIZON was the trial everyone in preventive cardiology was waiting on. More than 8,300 patients with established cardiovascular disease and elevated lipoprotein(a) got either pelacarsen — an injectable antisense drug that knocks Lp(a) down substantially, on the order of 80% in earlier-phase testing — or placebo, on top of standard therapy.

On September 4, 2026, Novartis released the topline result: no significant reduction in the combined risk of cardiovascular death, heart attack, stroke, and urgent stenting or bypass. The drug did its job on the lab report. It didn’t prevent events. “These are not the results we hoped for,” Novartis’s own chief medical officer said.

One detail worth noticing: patients in the trial were extremely well managed otherwise, with average LDL cholesterol around 66 mg/dL — far lower than what most first responders are running. That matters for how you read the result, and we’ll come back to it.

Why This Doesn’t Mean Your Lp(a) Number Is Meaningless

Some commentators jumped straight to “why measure it at all?” That’s an overcorrection.

Lp(a) is genetically set, barely moves with diet or exercise, and decades of data tie high levels to earlier heart attacks and aortic valve disease. That evidence didn’t vanish in September. The 2026 ACC/AHA cholesterol guidance still recommends measuring Lp(a) once in your lifetime — the same position European and Canadian guidelines have held for years.

What the trial challenges is the assumption that lowering Lp(a) with a drug, late in the game, in people whose other risk factors are already dialed in, prevents events. It’s possible Lp(a) does its damage over decades and intervening at 60 is too late. It’s possible this particular drug or population was wrong. The ongoing trials of other agents — olpasiran, lepodisiran, zerlasiran — will answer some of that.

For a 35-year-old firefighter, the practical value of the test was never “there’s a pill coming.” It was triage: a high Lp(a) tells you that your other numbers can’t be average. Sudden cardiac death is still the leading cause of on-duty death in the fire service, and a large share of those events happen in people who were never flagged as high risk. Lp(a) is one of the cheapest ways to find out you’re not allowed to coast.

What Actually Works If Your Lp(a) Is High

There is still no approved drug for Lp(a) itself. What the evidence supports is driving down every risk factor you can control — harder than the standard targets:

1. Get ApoB (or at minimum LDL-C) aggressively low. Remember the trial detail above: an LDL around 66 mg/dL was the background in Lp(a)HORIZON. If your Lp(a) is high and your LDL is sitting at 130 because your doc called it “borderline,” that’s the actionable problem. Statins, ezetimibe, and PCSK9 inhibitors all work; PCSK9 inhibitors even lower Lp(a) modestly.
2. Know your blood pressure on shift, not just at the physical. Shift work hypertension hides from single readings. A home cuff, used on duty days, tells the truth.
3. Consider a coronary calcium score if you’re over 40 (or over 35 with high Lp(a) plus family history). It’s the ~$100 scan that turns an abstract risk into a yes/no answer about plaque you already have.
4. Don’t smoke, and treat sleep apnea if you have it. Both multiply the risk that Lp(a) starts.
5. Ask your provider about aspirin. For some people with high Lp(a), low-dose aspirin may have a role in primary prevention — it’s an individualized call, not a blanket recommendation.

The Bottom Line for the Badge

A failed trial is still information. Pelacarsen’s miss tells us there’s no shortcut coming in the next few years — which makes the unglamorous work more valuable, not less. If you’ve never had Lp(a) measured, a once-in-a-lifetime test still belongs on your next lab order. If you already know yours is high, the play hasn’t changed: treat it as a mandate to make every modifiable number excellent, starting with ApoB and blood pressure, and get objective data with a calcium score when age-appropriate.

The system won’t do this for you — most department physicals still don’t include any of it. For guides on the labs to order, the questions to ask, and providers who actually understand first responder risk, keep up with us at policefire.health.

This article is for informational purposes only and does not constitute medical advice. BadgeBiohacking (policefire.health) is a comparison and review site. We may earn affiliate commissions from links on this site. Always consult a qualified healthcare provider before starting any treatment.